Who are Finacea® (Azelaic Acid) Foam's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): azelaic acid 15% gel, Azelaic Acid Cream, Generic Azelaic Acid Foam, Azelaic acid foam.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/finacea-azelaic-acid-foam.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Finacea® (Azelaic Acid) Foam — Competitive Intelligence Brief

Finacea® (Azelaic Acid) Foam (Finacea® (Azelaic Acid) Foam) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antimicrobial and anti-inflammatory agent. Area: Dermatology.

phase 3 Topical antimicrobial and anti-inflammatory agent Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Finacea® (Azelaic Acid) Foam (Finacea® (Azelaic Acid) Foam) — Actavis Inc.. Azelaic acid reduces inflammation and bacterial growth in the skin by inhibiting mitochondrial enzymes and reducing reactive oxygen species production.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Finacea® (Azelaic Acid) Foam TARGET	Finacea® (Azelaic Acid) Foam	Actavis Inc.	phase 3	Topical antimicrobial and anti-inflammatory agent
azelaic acid 15% gel	azelaic acid 15% gel	Galderma R&D	marketed	Topical antimicrobial and anti-inflammatory agent
Azelaic Acid Cream	Azelaic Acid Cream	LEO Pharma	marketed	Topical antimicrobial and anti-inflammatory agent
Generic Azelaic Acid Foam	Generic Azelaic Acid Foam	Actavis Inc.	phase 3	Topical antimicrobial and anti-inflammatory agent
Azelaic acid foam	Azelaic acid foam	Padagis LLC	phase 3	Topical antimicrobial and anti-inflammatory agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antimicrobial and anti-inflammatory agent class)

Actavis Inc. · 2 drugs in this class
Galderma R&D · 1 drug in this class
LEO Pharma · 1 drug in this class
Padagis LLC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Finacea® (Azelaic Acid) Foam — Competitive Intelligence Brief. https://druglandscape.com/ci/finacea-azelaic-acid-foam. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab